Learn how this inherited TP53 gene condition raises risk of many types of cancer, how it's diagnosed, and how screening can help find cancer early.
Update Date: 28.08.2026
Li-Fraumeni (LEE-frau-MEE-nee) syndrome is a rare inherited condition that increases the risk of many types of cancer. These cancers often happen at younger ages than usual. The syndrome also can lead to more than one cancer throughout life.
In the past, Li-Fraumeni syndrome has been called sarcoma, breast, leukemia and adrenal gland (SBLA) cancer syndrome. You also may see the condition spelled Li Fraumeni, without the hyphen.
Li-Fraumeni syndrome is linked to an inherited harmful change, also called a mutation, in the TP53 gene. The TP53 gene usually helps keep cells with damaged DNA from growing into cancer.
Li-Fraumeni syndrome is different from other inherited cancer syndromes because it involves a different gene. It also may be linked with different cancers. For example, Lynch syndrome is caused by changes in other genes that also play a role in managing DNA damage. Though Lynch syndrome also is linked to many cancers, it's especially linked to colon and endometrial cancers.
A diagnosis of Li-Fraumeni syndrome can feel overwhelming. But knowing about Li-Fraumeni syndrome can help you and your healthcare team take steps to screen for cancer early, when treatment may be more successful.
Li-Fraumeni syndrome doesn't cause symptoms itself. But it increases the risk of different types of cancer, which can cause different symptoms.
Some cancers commonly linked to Li-Fraumeni syndrome are:
Tell your healthcare team if you have any new or unexplained symptoms. This includes symptoms such as pain that lasts or gets worse.
Li-Fraumeni syndrome is caused by a harmful change in the TP53 gene, which is located on chromosome 17. The TP53 gene gives the body instructions to make a protein called p53. This protein helps stop cells with damaged DNA from growing and dividing. When TP53 doesn't work well, damaged cells may survive and grow. Over time, they may become cancer.
Li-Fraumeni syndrome often is inherited. When it's inherited, a person needs to inherit only one changed copy of the TP53 gene from a parent to have the syndrome. This is called an autosomal dominant pattern. If a parent has the harmful gene change, each child has a 50% chance of inheriting it.
In Li-Fraumeni syndrome, the TP53 gene change usually is a germline gene change. This means the change was present in the egg or sperm cell that formed a person, so it's found in almost every cell in the body. This is why the TP53 change can increase the risk of many different types of cancer.
Not everyone with Li-Fraumeni syndrome inherits the TP53 change from a parent. In some people, the gene change happens by chance. This is called a de novo variant.
Having a parent with the changed TP53 gene that causes Li-Fraumeni syndrome is the main risk factor for Li-Fraumeni syndrome. If either parent has the changed TP53 gene, the child has a 50% chance of inheriting it. This is called an autosomal dominant inheritance pattern.
In some people, the gene change is new. This means it wasn't inherited from either parent and happened by chance.
Li-Fraumeni syndrome greatly increases the risk of getting cancer. One study estimates that:
This is why regular cancer screening and medical exams throughout life are important — to find and treat cancer early.
The main complication of Li-Fraumeni syndrome is cancer. Research has estimated that the lifetime risk of cancer for someone with Li-Fraumeni syndrome is 90%, possibly more.
When it comes to cancer linked to Li-Fraumeni syndrome:
Cancer risk estimates for Li-Fraumeni syndrome, especially for specific types of cancer, can change depending on the study. Because Li-Fraumeni syndrome is rare, risk estimates may change as more people are studied. Cancer risk also depends on your age and sex and which TP53 change you have.
In general, cancers most strongly linked to Li-Fraumeni syndrome include:
Some TP53 gene changes, also called gene mutations, also increase the risk of certain cancers beyond those traditionally linked with Li-Fraumeni syndrome. They include:
There is no known way to prevent the gene change linked to Li-Fraumeni syndrome. However, early testing and regular screening and follow-up care, along with some other steps, may help manage the increased cancer risk that comes with Li-Fraumeni syndrome.
Your healthcare team may recommend some of the following steps.
Li-Fraumeni syndrome usually is diagnosed when a genetic test finds a harmful TP53 gene change. Before recommending genetic testing, the healthcare team also looks at your personal and family histories of cancer.
A healthcare team may recommend TP53 genetic testing if:
Two sets of criteria commonly used to decide if you need genetic testing are the classic Li-Fraumeni syndrome criteria and the Chompret criteria.
If all of these classic criteria apply, a care team may suggest genetic testing.
The classic criteria look for a pattern of cancer at young ages within a family.
The Chompret criteria aim to include people who may need testing even if their family does not meet the classic criteria.
If any of these Chompret criteria apply, a care team may suggest genetic testing:
Genetic testing may be considered in some other situations. These include when:
Genetic testing often looks for a harmful TP53 gene change using a blood sample.
Sometimes a TP53 gene change is found in only a small number of blood cells. When this happens, it could mean:
If a blood test shows that only some cells have the gene change, you may need testing of other body tissue, such as the skin. This can show if the gene change is present in other places in the body, which may suggest it's mosaic Li-Fraumeni syndrome.
A genetic counselor or other healthcare professional trained in genetics can help explain what the result means for the person being tested and for family members.
If you're diagnosed with Li-Fraumeni syndrome, regular cancer screening and medical exams are an important part of managing the risk of cancer. Some screening is recommended as early as infancy, and screening is done throughout life.
Screening may include:
Screening in adults also may include:
Your exact screening plan may be adjusted based on your age and personal and family cancer histories. Because Li-Fraumeni syndrome is rare and screening planning is complex, care often is coordinated by a team with experience in inherited cancer syndromes.
There is no treatment for the TP53 gene change that causes Li-Fraumeni syndrome. Treatment focuses on treating any cancer that forms.
When planning cancer treatment, the healthcare team also thinks about how treatments might affect a person's future cancer risk. This may include:
It may help to take steps to prepare for your appointments.
Before your appointment, it may help to gather information to bring with you.
It also may help to prepare a list of questions ahead of time. For Li-Fraumeni syndrome, some basic questions to ask may include:
© 2026 Mayo Foundation for Medical Education and Research. All rights reserved. Terms of Use